litlas
ログインアカウント作成

Oliver Sartor

1985–2025 年に発表

233
論文数
39,789
被引用数
98
h 指数
221
i10 指数

被引用数

Oliver Sartor の年別被引用数1988 年: 被引用 1 件1989 年: 被引用 1 件1990 年: 被引用 2 件1991 年: 被引用 1 件1992 年: 被引用 4 件1993 年: 被引用 8 件1994 年: 被引用 6 件1995 年: 被引用 19 件1996 年: 被引用 21 件1997 年: 被引用 38 件1998 年: 被引用 34 件1999 年: 被引用 34 件2000 年: 被引用 32 件2001 年: 被引用 52 件2002 年: 被引用 50 件2003 年: 被引用 46 件2004 年: 被引用 54 件2005 年: 被引用 58 件2006 年: 被引用 64 件2007 年: 被引用 58 件2008 年: 被引用 62 件2009 年: 被引用 88 件2010 年: 被引用 126 件2011 年: 被引用 133 件2012 年: 被引用 122 件2013 年: 被引用 187 件2014 年: 被引用 196 件2015 年: 被引用 212 件2016 年: 被引用 254 件2017 年: 被引用 272 件2018 年: 被引用 291 件2019 年: 被引用 953 件2020 年: 被引用 1,233 件2021 年: 被引用 1,541 件2022 年: 被引用 1,355 件2023 年: 被引用 1,082 件2024 年: 被引用 1,976 件2025 年: 被引用 1,008 件2026 年: 被引用 37 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,662 件、この内訳の 25.9%イギリス: 引用元論文 966 件、この内訳の 6.8%中国: 引用元論文 913 件、この内訳の 6.4%ドイツ: 引用元論文 891 件、この内訳の 6.3%イタリア: 引用元論文 781 件、この内訳の 5.5%カナダ: 引用元論文 723 件、この内訳の 5.1%フランス: 引用元論文 636 件、この内訳の 4.5%オーストラリア: 引用元論文 518 件、この内訳の 3.7%スイス: 引用元論文 438 件、この内訳の 3.1%スペイン: 引用元論文 435 件、この内訳の 3.1%オランダ: 引用元論文 428 件、この内訳の 3%日本: 引用元論文 378 件、この内訳の 2.7%
0%25.9%その他 23.9%

機関

分野

  • Medicine74.2%
  • Biochemistry, Genetics and Molecular Biology16.5%
  • Immunology and Microbiology2.5%
  • Health Professions1.2%
  • Materials Science1%
  • Engineering0.9%
  • その他3.7%

トピック

  • Prostate Cancer Treatment and Research17.3%
  • Prostate Cancer Diagnosis and Treatment9.7%
  • Radiopharmaceutical Chemistry and Applications6.8%
  • PARP inhibition in cancer therapy2.6%
  • Cancer, Lipids, and Metabolism2.3%
  • Cancer Genomics and Diagnostics2.1%
  • その他59.2%

共著者

全論文

検索で開く
  1. Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

    著者: Oliver Sartor, Johann S. de Bono, Kim N., Karim Fizazi, Ken Herrmann, Kambiz Rahbar, Scott T. Tagawa, Luke T. Nordquist, Nitin Vaishampayan, Ghassan El‐Haddad, Chandler H. Park, Tomasz M. Beer, Alison Armour, Wendy J. Pérez-Contreras, Michelle DeSilvio, Euloge Kpamegan, Germo Gericke, Richard A. Messmann, Michael J. Morris, Bernd J. Krause - New England Journal of Medicine 2021 被引用: 2,598

  2. Olaparib for Metastatic Castration-Resistant Prostate Cancer

    著者: Johann S. de Bono, Joaquı́n Mateo, Karim Fizazi, Fred Saad, Neal D. Shore, Shahneen Sandhu, Kim N., Oliver Sartor, Neeraj Agarwal, David Olmos, Antoine Thiery-Vuillemin, Przemyslaw Twardowski, Niven Mehra, Carsten Goessl, Jinyu Kang, Joseph E. Burgents, Wenting Wu, Alexander Kohlmann, Carrie A. Adelman, Maha Hussain - New England Journal of Medicine 2020 被引用: 2,237

  3. Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

    著者: Howard I. Scher, Michael J. Morris, Walter M. Stadler, Celestia S. Higano, Ethan Basch, Karim Fizazi, Emmanuel S. Antonarakis, Tomasz M. Beer, Michael A. Carducci, Kim N., Paul G. Corn, Johann S. de Bono, Robert Dreicer, Daniel J. George, Elisabeth I. Heath, Maha Hussain, Wm. Kevin Kelly, Glenn Liu, Christopher J. Logothetis, David M. Nanus, Mark N. Stein, Dana E. Rathkopf, Susan F. Slovin, Charles J. Ryan, Oliver Sartor, Eric J. Small, Matthew Raymond Smith, Cora N. Sternberg, Mary-Ellen Taplin, George Wilding, Peter S. Nelson, Lawrence H. Schwartz, Susan Halabi, Philip W. Kantoff, Andrew J. Armstrong - Journal of Clinical Oncology 2016 被引用: 1,603

  4. Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

    著者: Chris Parker, Sten Nilsson, Daniel Heinrich, Svein Inge Helle, Joe M. O’Sullivan, Sophie D. Fosså, Aleš Chodacki, Paweł Wiechno, John Logue, M. Seke, Anders Widmark, Dag Clement Johannessen, Peter Hoskin, David Bottomley, Nicholas D. James, A. Solberg, Isabel Syndikus, J. Kliment, Saskia Wedel, S. Boehmer, Marcos F. Dall’Oglio, Lars Franzén, Robert E. Coleman, Nicholas J. Vogelzang, C. Gillies O'Bryan-Tear, K. Staudacher, J. Garcia‐Vargas, Minghua Shan, Øyvind S. Bruland, Oliver Sartor - New England Journal of Medicine 2013 被引用: 3,343

  5. Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer

    著者: Maha Hussain, Joaquı́n Mateo, Karim Fizazi, Fred Saad, Neal D. Shore, Shahneen Sandhu, Kim N., Oliver Sartor, Neeraj Agarwal, David Olmos, Antoine Thiery-Vuillemin, Przemyslaw Twardowski, Guilhem Roubaud, Mustafa Özgüroğlu, Jinyu Kang, Joseph E. Burgents, Christopher Gresty, Claire Corcoran, Carrie A. Adelman, Johann S. de Bono - New England Journal of Medicine 2020 被引用: 766

  6. Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial

    著者: Fred Saad, Noel W. Clarke, Mototsugu Oya, Neal D. Shore, Giuseppe Procopio, João Daniel Guedes, Cagatay Arslan, Niven Mehra, Francis Parnis, Emma Brown, Friederike Schlürmann, Jae Young Joung, Mikio Sugimoto, Oliver Sartor, Yuzhen Liu, Christian Poehlein, Laura Barker, Paula Michelle del Rosario, Andrew J. Armstrong - The Lancet Oncology 2023 被引用: 288

  7. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

    著者: Johann S. de Bono, Stéphane Oudard, Mustafa Özgüroğlu, Steinbjørn Hansen, Jean-Pascal Machiels, Ivo Kocák, Gwénaëlle Gravis, I. Bodrogi, Mary J. MacKenzie, Liji Shen, Martin Roessner, Sunil Gupta, Oliver Sartor - The Lancet 2010 被引用: 3,284

  8. Phase 1/2 study of ARV-110, an androgen receptor (AR) PROTAC degrader, in metastatic castration-resistant prostate cancer (mCRPC).

    著者: Xīn Gào, Howard A. Burris, Jacqueline Vuky, Robert Dreicer, Oliver Sartor, Cora N. Sternberg, Ivor Percent, Maha Hussain, Arash Rezazadeh Kalebasty, John Shen, Elisabeth I. Heath, Guillermo Abesada‐Terk, Sunil Gandhi, Meredith McKean, Haolan Lu, Elmer Berghorn, Richard Gedrich, S. Debbie Chirnomas, Nicholas J. Vogelzang, Daniel P. Petrylak - Journal of Clinical Oncology 2022 被引用: 186

  9. Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

    著者: Silke Gillessen, Alberto Bossi, Ian D. Davis, Johann S. de Bono, Karim Fizazi, Nicholas D. James, Nicolas Mottet, Neal D. Shore, Eric J. Small, Matthew R. Smith, Christopher J. Sweeney, Bertrand Tombal, Emmanuel S. Antonarakis, Ana M. Aparicio, Andrew J. Armstrong, Gerhardt Attard, Tomasz M. Beer, Himisha Beltran, Anders Bjartell, Pierre Blanchard, Alberto Briganti, Robert G. Bristow, Muhammad Bulbul, Orazio Caffo, Daniel Castellano, Elena Castro, Heather H. Cheng, Kim N., Simon Chowdhury, Caroline S. Clarke, Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Ross Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Dan George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raja Leibowitz, Christopher Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Amee Morgans, Michael J. Morris, Hind M’rabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki ほか 18 名 - European Journal of Cancer 2023 被引用: 157

  10. Metastatic Prostate Cancer

    著者: Oliver Sartor, Johann S. de Bono - New England Journal of Medicine 2018 被引用: 552

  11. 177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial

    著者: Michael J. Morris, Daniel Castellano, Ken Herrmann, Johann S. de Bono, Neal D. Shore, Kim N., Michael J. Crosby, Josep M. Piulats, Aude Fléchon, Xiao X. Wei, Hakim Mahammedi, Guilhem Roubaud, Hana Študentová, James Nagarajah, Begoña Mellado, Álvaro Montesa-Pino, Euloge Kpamegan, Samson Ghebremariam, Teri Kreisl, Celine Wilke, Katja Lehnhoff, Oliver Sartor, Karim Fizazi - The Lancet 2024 被引用: 258

  12. Health-related quality of life and pain outcomes with [177Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial

    著者: Karim Fizazi, Ken Herrmann, Bernd J. Krause, Kambiz Rahbar, Kim N., Michael J. Morris, Oliver Sartor, Scott T. Tagawa, A. Tuba Kendi, Nicholas J. Vogelzang, Jérémie Calais, James Nagarajah, Xiao X. Wei, Vadim S. Koshkin, Jean‐Mathieu Beauregard, Brian Chang, Ray Ghouse, Michelle DeSilvio, Richard A. Messmann, Johann S. de Bono - The Lancet Oncology 2023 被引用: 109

  13. Targeted Alpha-Particle Therapy: A Review of Current Trials

    著者: Albert Jang, A. Tuba Kendi, Geoffrey B. Johnson, Þorvarður R. Hálfdánarson, Oliver Sartor - International Journal of Molecular Sciences 2023 被引用: 101

  14. Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer

    著者: Wanling Xie, Meredith M. Regan, Marc Buyse, Susan Halabi, Philip W. Kantoff, Oliver Sartor, Howard R. Soule, Noel W. Clarke, Laurence Collette, James J. Dignam, Karim Fizazi, Wendy R. Paruleker, Howard M. Sandler, Matthew R. Sydes, Bertrand Tombal, Scott Williams, Christopher J. Sweeney, on behalf of the ICECaP Working Group - Journal of Clinical Oncology 2017 被引用: 434

  15. CDK12-Altered Prostate Cancer: Clinical Features and Therapeutic Outcomes to Standard Systemic Therapies, Poly (ADP-Ribose) Polymerase Inhibitors, and PD-1 Inhibitors

    著者: Emmanuel S. Antonarakis, Pedro Isaacsson Velho, Wei Fu, Hao Wang, Neeraj Agarwal, Víctor Sacristán Santos, Benjamin L. Maughan, Роберто Пили, Nabil Adra, Cora N. Sternberg, Panagiotis J. Vlachostergios, Scott T. Tagawa, Alan H. Bryce, Andrea McNatty, Zachery R. Reichert, Robert Dreicer, Oliver Sartor, Tamara L. Lotan, Maha Hussain - JCO Precision Oncology 2020 被引用: 206

  16. Theranostics and artificial intelligence: new frontiers in personalized medicine

    著者: Gokce Belge Bilgin, Cem Bilgin, Brian J. Burkett, Jacob J. Orme, Daniel S. Childs, Matthew Thorpe, Þorvarður R. Hálfdánarson, Geoffrey B. Johnson, A. Tuba Kendi, Oliver Sartor - Theranostics 2024 被引用: 107

  17. LBA13 Phase III trial of [177Lu]Lu-PSMA-617 in taxane-naive patients with metastatic castration-resistant prostate cancer (PSMAfore)

    著者: Oliver Sartor, D.E. Castellano Gauna, Ken Herrmann, Johann S. de Bono, Neal D. Shore, K.N. Chi, M. J. Crosby, J.M. Piulats Rodriguez, Aude Fléchon, X.X. Wei, Hakim Mahammedi, Guilhem Roubaud, H. ova, Samson Ghebremariam, Euloge Kpamegan, Teri Kreisl, Neda Delgoshaie, Katja Lehnhoff, Michael J. Morris, Karim Fizazi - Annals of Oncology 2023 被引用: 68

  18. The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial

    著者: Alan Pollack, Theodore Karrison, Alexander G. Balogh, Leonard G. Gomella, Daniel A. Low, Deborah Watkins Bruner, Jeffrey S. Wefel, André‐Guy Martin, Jeff M. Michalski, Steve Angyalfi, Himanshu Lukka, Sergio Faria, George Rodrigues, Marie-Claude Beauchemin, R. Jeffrey Lee, Samantha A. Seaward, Aaron M. Allen, Drew C. Monitto, Wendy Seiferheld, Oliver Sartor, Felix Feng, Howard M. Sandler - The Lancet 2022 被引用: 251

  19. Status of PSMA-targeted radioligand therapy in prostate cancer: current data and future trials

    著者: Albert Jang, A. Tuba Kendi, Oliver Sartor - Therapeutic Advances in Medical Oncology 2023 被引用: 96

  20. Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial—FIRSTANA

    著者: Stéphane Oudard, Karim Fizazi, Lisa Sengeløv, Gedske Daugaard, Fred Saad, Steinbjørn Hansen, Marie Hjälm-Eriksson, Jacek Jassem, Antoine Thiery-Vuillemin, Orazio Caffo, Daniel Castellano, Paul N. Mainwaring, John Bernard, Liji Shen, Mustapha Chadjaa, Oliver Sartor - Journal of Clinical Oncology 2017 被引用: 356

  21. Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer

    著者: William U. Shipley, Wendy Seiferheld, Himanshu Lukka, Pierre Major, Niall M. Heney, David J. Grignon, Oliver Sartor, Maltibehn P. Patel, Jean-Paul Bahary, Anthony L. Zietman, Thomas M. Pisansky, Kenneth L. Zeitzer, C.A. Lawton, Felix Y. Feng, R.D. Lovett, Alexander G. Balogh, Luís Souhami, Seth A. Rosenthal, K. Kerlin, James J. Dignam, Stephanie L. Pugh, Howard M. Sandler - New England Journal of Medicine 2017 被引用: 662

  22. Neoplastic Reprogramming of Patient-Derived Adipose Stem Cells by Prostate Cancer Cell-Associated Exosomes

    著者: Zakaria Y. Abd Elmageed, Yijun Yang, Raju Thomas, Manish Ranjan, Debasis Mondal, Krzysztof Moroz, Zhide Fang, Bashir M. Rezk, Krishnarao Moparty, Suresh C. Sikka, Oliver Sartor, Asim B. Abdel‐Mageed - Stem Cells 2013 被引用: 298

  23. Treatment Patterns and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer in a Real-world Clinical Practice Setting in the United States

    著者: Daniel J. George, Oliver Sartor, Kurt Miller, Fred Saad, Bertrand Tombal, Ján Kalinovský, Xiaolong Jiao, Krishna Tangirala, Cora N. Sternberg, Celestia S. Higano - Clinical Genitourinary Cancer 2020 被引用: 176

  24. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019

    著者: Veda N. Giri, Karen E. Knudsen, William Kevin Kelly, Heather H. Cheng, Kathleen A. Cooney, Michael S. Cookson, William L. Dahut, Scott M. Weissman, Howard R. Soule, Daniel P. Petrylak, Adam P. Dicker, Saud H. AlDubayan, Amanda E. Toland, Colin C. Pritchard, Curtis A. Pettaway, Mary B. Daly, James L. Mohler, J. Kellogg Parsons, Peter R. Carroll, Robert Pilarski, Amie Blanco, Ashley Woodson, Alanna Kulchak Rahm, Mary-Ellen Taplin, Thomas J. Polascik, Brian T. Helfand, Colette Hyatt, Alicia K. Morgans, Felix Y. Feng, Michael P. Mullane, Jacqueline Powers, Raoul S. Concepcion, Daniel W. Lin, Richard C. Wender, James Ryan Mark, Anthony J. Costello, Arthur L. Burnett, Oliver Sartor, William B. Isaacs, Jianfeng Xu, Jeffrey N. Weitzel, Gerald L. Andriole, Himisha Beltran, Alberto Briganti, Lindsey Byrne, Anne Calvaresi, Thenappan Chandrasekar, David Y.T. Chen, Robert B. Den, Albert Dobi, E. David Crawford, James A. Eastham, Scott E. Eggener, Matthew L. Freedman, Marc B. Garnick, Patrick T. Gomella, Nathan Handley, Mark Hurwitz, Joseph K. Izes, R. Jeffrey Karnes, Costas D. Lallas, Lucia R. Languino, Stacy Loeb, Ana María López, Kevin R. Loughlin, Grace Lu‐Yao, S. Bruce Malkowicz, Mark Mann, Patrick Mille, Martin Miner, Todd M. Morgan, José Moreno, Lorelei A. Mucci, Ronald E. Myers, Sarah M. Nielsen, Brock O’Neil, Wayne H. Pinover, Peter A. Pinto, Wendy Poage, Ganesh V. Raj, Timothy R. Rebbeck, Charles J. Ryan, Howard M. Sandler, Matthew J. Schiewer, Emily Scott, Brittany M. Szymaniak, William Tester, Edouard J. Trabulsi, Neha Vapiwala, Evan Y. Yu, Charnita Zeigler‐Johnson, Leonard G. Gomella - Journal of Clinical Oncology 2020 被引用: 279